| HRIIX | TIDDX | HRIIX / TIDDX | |
| Total Expense Ratio | 1.51 | 1.08 | 140% |
| Annual Report Gross Expense Ratio | 2.36 | 1.09 | 217% |
| Fund Existence | 2 years | 10 years | - |
| Gain YTD | 10.506 | 2.811 | 374% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 500000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 228M | 6.44B | 4% |
| Annual Yield % from dividends | 1.20 | 1.69 | 71% |
| Returns for 1 year | 55.52 | 29.74 | 187% |
| Returns for 3 years | N/A | 34.39 | - |
| Returns for 5 years | N/A | -12.79 | - |
| Returns for 10 years | N/A | 69.70 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| QIACX | 53.61 | -0.12 | -0.22% |
| Federated Hermes MDT All Cap Core IS | |||
| VWNEX | 76.79 | -0.18 | -0.23% |
| Vanguard Windsor™ Admiral™ | |||
| EMRZX | 19.27 | -0.18 | -0.93% |
| VanEck Emerging Markets Z | |||
| VPRDX | 11.11 | -0.11 | -0.98% |
| VY® Morgan Stanley Global Franchise R6 | |||
| BIVSX | 16.78 | -0.38 | -2.21% |
| Invenomic Super Institutional | |||